Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Colorectal Neoplasms

  Free Subscription


01.01.2020

1 Am J Clin Oncol
1 Am J Epidemiol
2 Am J Surg
2 Ann Oncol
6 Ann Surg
13 Ann Surg Oncol
4 Anticancer Res
11 BMC Cancer
1 BMC Gastroenterol
3 Br J Cancer
6 Cancer
4 Cancer Lett
5 Cancer Res
1 Eur J Gastroenterol Hepatol
5 Gastroenterology
1 Gastrointest Endosc
3 Gut
6 Int J Cancer
10 Int J Colorectal Dis
1 Int J Oncol
4 J Clin Oncol
1 J Natl Cancer Inst
3 J Pathol
3 J Surg Oncol
1 Lancet
1 Nat Rev Cancer
4 Oncogene
2 Oncol Rep
5 PLoS One
1 World J Surg


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Oncol

  1. LEHRER S, Rheinstein PH
    Increased Risk of Acute Myelogenous Leukemia After Early Onset but Not Late-Onset Colorectal Cancer.
    Am J Clin Oncol. 2019 Dec 23. doi: 10.1097/COC.0000000000000658.
    PubMed     Text format     Abstract available


    Am J Epidemiol

  2. DORIA-ROSE VP, Kamineni A, Barrett MJ, Ko CW, et al
    Case-Control Studies of the Efficacy of Screening Tests That Seek to Prevent Cancer Incidence: Results of an Approach That Utilizes Administrative Claims Data That Do Not Provide Information Regarding Test Indication.
    Am J Epidemiol. 2019;188:703-708.
    PubMed     Text format     Abstract available


    Am J Surg

  3. OKABE H, Ohsaki T, Ogawa K, Ozaki N, et al
    Frailty predicts severe postoperative complications after elective colorectal surgery.
    Am J Surg. 2019;217:677-681.
    PubMed     Text format     Abstract available

  4. ZHAO B, Lopez NE, Eisenstein S, Schnickel GT, et al
    Synchronous metastatic colon cancer and the importance of primary tumor laterality - A National Cancer Database analysis of right- versus left-sided colon cancer.
    Am J Surg. 2019 Dec 12. pii: S0002-9610(19)31553.
    PubMed     Text format     Abstract available


    Ann Oncol

  5. SVEEN A, Cremolini C, Dienstmann R
    Predictive modeling in colorectal cancer: time to move beyond consensus molecular subtypes.
    Ann Oncol. 2019;30:1682-1685.
    PubMed     Text format    

  6. STINTZING S, Wirapati P, Lenz HJ, Neureiter D, et al
    Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial.
    Ann Oncol. 2019;30:1796-1803.
    PubMed     Text format     Abstract available


    Ann Surg

  7. VIGANO L, Costa G, Toso C, Cimino M, et al
    Comment on "Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases."
    Ann Surg. 2019;269:e47-e49.
    PubMed     Text format    

  8. LAMENDELLA R, Stewart DB
    Comment on "Mucus Microbiome of Anastomotic Tissue During Surgery Has Predictive Value for Colorectal Anastomotic Leakage".
    Ann Surg. 2019;269:e68-e69.
    PubMed     Text format    

  9. GIGLIO MC, Troisi RI
    Comment on "ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis".
    Ann Surg. 2019;269:e32.
    PubMed     Text format    

  10. MARGONIS GA, Andreatos N, Wolfgang CL, Weiss MJ, et al
    Response to the Comment on "Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases."
    Ann Surg. 2019;269:e49-e51.
    PubMed     Text format    

  11. VAN PRAAGH JB, de Goffau MC, Harmsen HJM, Havenga K, et al
    Response to Comment on "Mucus Microbiome of Anastomotic Tissue During Surgery Has Predictive Value for Colorectal Anastomotic Leakage".
    Ann Surg. 2019;269:e69-e70.
    PubMed     Text format    

  12. KALTENMEIER C, Shen C, Medich DS, Geller DA, et al
    Time to Surgery and Colon Cancer Survival in the United States.
    Ann Surg. 2019 Dec 10. doi: 10.1097/SLA.0000000000003745.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  13. FIELDS AC, McCarty JC, Lu P, Vierra BM, et al
    Colon Neuroendocrine Tumors: A New Lymph Node Staging Classification.
    Ann Surg Oncol. 2019;26:2028-2036.
    PubMed     Text format     Abstract available

  14. MATSUDA T, Hasegawa H, Yamashita K, Takase N, et al
    Laparoscopic Complete Mesocolic Excision for Double Flexural Colon Cancers.
    Ann Surg Oncol. 2019;26:2516.
    PubMed     Text format     Abstract available

  15. FERNANDEZ LM, Perez RO
    Longer Intervals from Neoadjuvant Therapy to Rectal Cancer Surgery: The Clock is Ticking....
    Ann Surg Oncol. 2019;26:1957-1958.
    PubMed     Text format    

  16. ROXBURGH CSD, Strombom P, Lynn P, Gonen M, et al
    Role of the Interval from Completion of Neoadjuvant Therapy to Surgery in Postoperative Morbidity in Patients with Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2019;26:2019-2027.
    PubMed     Text format     Abstract available

  17. KONISHI T, Shinozaki E, Murofushi K, Taguchi S, et al
    Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal Cancer.
    Ann Surg Oncol. 2019;26:2507-2513.
    PubMed     Text format     Abstract available

  18. ARJONA-SANCHEZ A, Rodriguez-Ortiz L
    ASO Author Reflections: Tending Towards a Personalized Medicine for Colorectal Carcinomatosis by Adding the RAS Mutation Status in the Workup for CRS and HIPEC.
    Ann Surg Oncol. 2019;26:2605-2606.
    PubMed     Text format    

  19. HALVERSON AL, Morris AM, Cleary RK, Chang GJ, et al
    For Patients with Early Rectal Cancer, Does Local Excision Have an Impact on Recurrence, Survival, and Quality of Life Relative to Radical Resection?
    Ann Surg Oncol. 2019;26:2497-2506.
    PubMed     Text format     Abstract available

  20. YANG Y, Malakorn S, Maldonado K, Bednarski BK, et al
    The Pelvis-First Approach for Robotic Proctectomy in Patients with Redundant Abdominal Colon.
    Ann Surg Oncol. 2019;26:2514-2515.
    PubMed     Text format     Abstract available

  21. ARJONA-SANCHEZ A, Rodriguez-Ortiz L, Baratti D, Schneider MA, et al
    RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score.
    Ann Surg Oncol. 2019;26:2595-2604.
    PubMed     Text format     Abstract available

  22. KWAAN MR
    Postoperative CEA and Other Non-traditional Risk Factors for Colon Cancer Recurrence: Findings from Swedish Population-Based Data.
    Ann Surg Oncol. 2019 Dec 18. pii: 10.1245/s10434-019-08151.
    PubMed     Text format    

  23. SHULMAN LN
    Dr Charlton et al., Commentary and Complementary Data to Add to "Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regio
    Ann Surg Oncol. 2019 Dec 19. pii: 10.1245/s10434-019-08152.
    PubMed     Text format    

  24. OSTERMAN E, Glimelius B
    ASO Author Reflections: Emerging Risk Factors in Colon Cancer-End of the Line for Clinomics?
    Ann Surg Oncol. 2019 Dec 28. pii: 10.1245/s10434-019-08149.
    PubMed     Text format    

  25. HENTZEN JEKR, Rovers KP, Kuipers H, van der Plas WY, et al
    Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
    Ann Surg Oncol. 2019;26:2210-2221.
    PubMed     Text format     Abstract available


    Anticancer Res

  26. SOHN M, Agha A, Trum S, Moser C, et al
    Frequency of Polyps and Adenocarcinoma in Colon Interposition After Esophagectomy in Adulthood - A Systematic Review.
    Anticancer Res. 2019;39:6419-6430.
    PubMed     Text format     Abstract available

  27. CIZMARIKOVA M, Takac P, Spengler G, Kincses A, et al
    New Chalcone Derivative Inhibits ABCB1 in Multidrug Resistant T-cell Lymphoma and Colon Adenocarcinoma Cells.
    Anticancer Res. 2019;39:6499-6505.
    PubMed     Text format     Abstract available

  28. FIORI E, Crocetti D, Lamazza A, DE Felice F, et al
    Resection or Stenting in the Treatment of Symptomatic Advanced Metastatic Rectal Cancer: A Dilemma.
    Anticancer Res. 2019;39:6781-6786.
    PubMed     Text format     Abstract available

  29. DE FELICE F, Siniscalchi B, Bulzonetti N, Caiazzo R, et al
    Tolerability of Oxaliplatin-based Neoadjuvant Chemoradiotherapy in Elderly Locally Advanced Rectal Cancer Patients: A Case-control Study of a Real-life Experience.
    Anticancer Res. 2019;39:6957-6963.
    PubMed     Text format     Abstract available


    BMC Cancer

  30. CHEN Y, Yang X, Wen Z, Liu Y, et al
    Association between high-resolution MRI-detected extramural vascular invasion and tumour microcirculation estimated by dynamic contrast-enhanced MRI in rectal cancer: preliminary results.
    BMC Cancer. 2019;19:498.
    PubMed     Text format     Abstract available

  31. VRINTEN C, Gallagher A, Waller J, Marlow LAV, et al
    Cancer stigma and cancer screening attendance: a population based survey in England.
    BMC Cancer. 2019;19:566.
    PubMed     Text format     Abstract available

  32. LEKOANE KMB, Kuupiel D, Mashamba-Thompson TP, Ginindza TG, et al
    Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review.
    BMC Cancer. 2019;19:563.
    PubMed     Text format     Abstract available

  33. DUDANI S, Marginean H, Tang PA, Monzon JG, et al
    Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
    BMC Cancer. 2019;19:664.
    PubMed     Text format     Abstract available

  34. GEMOLL T, Miroll E, Klein O, Lischka A, et al
    Spatial UBE2N protein expression indicates genomic instability in colorectal cancers.
    BMC Cancer. 2019;19:710.
    PubMed     Text format     Abstract available

  35. SONG N, Lee J, Cho S, Kim J, et al
    Evaluation of gene-environment interactions for colorectal cancer susceptibility loci using case-only and case-control designs.
    BMC Cancer. 2019;19:1231.
    PubMed     Text format     Abstract available

  36. ZHANG X, Sun H, Chen W, He X, et al
    Elevated expression of AGGF1 predicts poor prognosis and promotes the metastasis of colorectal cancer.
    BMC Cancer. 2019;19:1252.
    PubMed     Text format     Abstract available

  37. KOTANI D, Kuboki Y, Horasawa S, Kaneko A, et al
    Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer.
    BMC Cancer. 2019;19:1253.
    PubMed     Text format     Abstract available

  38. SASTRE D, Baiochi J, de Souza Lima IM, Canto de Souza F, et al
    Focused screening reveals functional effects of microRNAs differentially expressed in colorectal cancer.
    BMC Cancer. 2019;19:1239.
    PubMed     Text format     Abstract available

  39. ABRAHAMSSON H, Porojnicu AC, Lindstrom JC, Dueland S, et al
    High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer.
    BMC Cancer. 2019;19:488.
    PubMed     Text format     Abstract available

  40. TSAOUSIS GN, Papadopoulou E, Apessos A, Agiannitopoulos K, et al
    Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
    BMC Cancer. 2019;19:535.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  41. MATSON AG, Bunting JP, Kaul A, Smith DJ, et al
    A non-randomised single centre cohort study, comparing standard and modified bowel preparations, in adults with cystic fibrosis requiring colonoscopy.
    BMC Gastroenterol. 2019;19:89.
    PubMed     Text format     Abstract available


    Br J Cancer

  42. HOU P, Shi P, Jiang T, Yin H, et al
    DKC1 enhances angiogenesis by promoting HIF-1alpha transcription and facilitates metastasis in colorectal cancer.
    Br J Cancer. 2019 Dec 20. pii: 10.1038/s41416-019-0695.
    PubMed     Text format     Abstract available

  43. STROWITZKI MJ, Radhakrishnan P, Pavicevic S, Scheer J, et al
    High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases.
    Br J Cancer. 2019;120:675-688.
    PubMed     Text format     Abstract available

  44. MARTIN V, Chiriaco C, Modica C, Acquadro A, et al
    Met inhibition revokes IFNgamma-induction of PD-1 ligands in MET-amplified tumours.
    Br J Cancer. 2019;120:527-536.
    PubMed     Text format     Abstract available


    Cancer

  45. FEDEWA SA, Siegel RL, Goding Sauer A, Bandi P, et al
    Colorectal cancer screening patterns after the American Cancer Society's recommendation to initiate screening at age 45 years.
    Cancer. 2019 Dec 18. doi: 10.1002/cncr.32662.
    PubMed     Text format    

  46. ONYEAGHALA G, Lintelmann AK, Joshu CE, Lutsey PL, et al
    Adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention guidelines and colorectal cancer incidence among African Americans and whites: The Atherosclerosis Risk in Communities study.
    Cancer. 2019 Dec 24. doi: 10.1002/cncr.32616.
    PubMed     Text format     Abstract available

  47. SAAD AM, Gad MM, Al-Husseini MJ, AlKhayat MA, et al
    Suicidal death within a year of a cancer diagnosis: A population-based study.
    Cancer. 2019;125:972-979.
    PubMed     Text format     Abstract available

  48. RIGTER LS, Spaander MCW, Aleman BMP, Bisseling TM, et al
    High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors.
    Cancer. 2018 Dec 18. doi: 10.1002/cncr.31903.
    PubMed     Text format     Abstract available

  49. RICE K, Sharma K, Li C, Butterly L, et al
    Cost-effectiveness of a patient navigation intervention to increase colonoscopy screening among low-income adults in New Hampshire.
    Cancer. 2018 Dec 12. doi: 10.1002/cncr.31864.
    PubMed     Text format     Abstract available

  50. CORRIGAN KL, Wall KC, Bartlett JA, Suneja G, et al
    Cancer disparities in people with human immunodeficiency virus: A systematic review of screening for non-AIDS-defining malignancies.
    Cancer. 2019 Jan 15. doi: 10.1002/cncr.31838.
    PubMed     Text format     Abstract available


    Cancer Lett

  51. GAO T, Hu Q, Hu X, Lei Q, et al
    Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis.
    Cancer Lett. 2019;445:11-23.
    PubMed     Text format     Abstract available

  52. TIAN X, Liu K, Zu X, Ma F, et al
    3,3'-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1/2 and ERK1/2.
    Cancer Lett. 2019;448:20-30.
    PubMed     Text format     Abstract available

  53. HILLERT EK, Brnjic S, Zhang X, Mazurkiewicz M, et al
    Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation.
    Cancer Lett. 2019;448:70-83.
    PubMed     Text format     Abstract available

  54. WANG Q, Dai L, Wang Y, Deng J, et al
    Targeted demethylation of the SARI promotor impairs colon tumour growth.
    Cancer Lett. 2019;448:132-143.
    PubMed     Text format     Abstract available


    Cancer Res

  55. BISHNUPURI KS, Alvarado DM, Khouri AN, Shabsovich M, et al
    IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis.
    Cancer Res. 2019;79:1138-1150.
    PubMed     Text format     Abstract available

  56. LIU Y, Deguchi Y, Tian R, Wei D, et al
    Pleiotropic Effects of PPARD Accelerate Colorectal Tumorigenesis, Progression, and Invasion.
    Cancer Res. 2019;79:954-969.
    PubMed     Text format     Abstract available

  57. COCCO E, Benhamida J, Middha S, Zehir A, et al
    Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions.
    Cancer Res. 2019;79:1047-1053.
    PubMed     Text format     Abstract available

  58. SALEM M, Wallace C, Velegraki M, Li A, et al
    GARP Dampens Cancer Immunity by Sustaining Function and Accumulation of Regulatory T Cells in the Colon.
    Cancer Res. 2019;79:1178-1190.
    PubMed     Text format     Abstract available

  59. RAJENDRAN P, Johnson G, Li L, Chen YS, et al
    Acetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain Inhibition.
    Cancer Res. 2019;79:918-927.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  60. MANNUCCI A, Zuppardo RA, Crippa S, Carrera P, et al
    MSH6 gene pathogenic variant identified in familial pancreatic cancer in the absence of colon cancer.
    Eur J Gastroenterol Hepatol. 2019 Dec 16. doi: 10.1097/MEG.0000000000001617.
    PubMed     Text format     Abstract available


    Gastroenterology

  61. GAVRIC A, Dezman R, Stabuc B
    An Enigmatic Mass in the Ascending Colon.
    Gastroenterology. 2019;157:1210-1212.
    PubMed     Text format    

  62. MURPHY N, Carreras-Torres R, Song M, Chan AT, et al
    Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses.
    Gastroenterology. 2019 Dec 26. pii: S0016-5085(19)41951.
    PubMed     Text format     Abstract available

  63. EAST JE
    Can Colonoscopy Sow the Seeds of Colorectal Cancer?
    Gastroenterology. 2019;157:1192-1195.
    PubMed     Text format    

  64. ALBENIZ E, Alvarez MA, Espinos JC, Nogales O, et al
    Clip Closure After Resection of Large Colorectal Lesions With Substantial Risk of Bleeding.
    Gastroenterology. 2019;157:1213-1221.
    PubMed     Text format     Abstract available

  65. ARCHAMBAULT AN, Su YR, Jeon J, Thomas M, et al
    Cumulative Burden of Colorectal Cancer-Associated Genetic Variants is More Strongly Associated With Early-onset vs Late-onset Cancer.
    Gastroenterology. 2019 Dec 19. pii: S0016-5085(19)41937.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  66. ZENGIN H, Kav T
    Complete colonoscopy is a difficult task in patients with gastric surgeries.
    Gastrointest Endosc. 2019;90:995.
    PubMed     Text format    


    Gut

  67. ZORZI M, Cavestro GM, Guzzinati S, Dal Maso L, et al
    Decline in the incidence of colorectal cancer and the associated mortality in young Italian adults.
    Gut. 2019 Dec 16. pii: gutjnl-2019-320406. doi: 10.1136/gutjnl-2019-320406.
    PubMed     Text format    

  68. MA W, Chan AT
    Antibiotic use and colorectal cancer: a causal association?
    Gut. 2019 Dec 24. pii: gutjnl-2019-319792. doi: 10.1136/gutjnl-2019-319792.
    PubMed     Text format    

  69. BLEIJENBERG AG, IJspeert JE, van Herwaarden YJ, Carballal S, et al
    Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort study.
    Gut. 2020;69:112-121.
    PubMed     Text format     Abstract available


    Int J Cancer

  70. WEI F, Su Y, Yao X, Cui X, et al
    Sex differences in the incidence and clearance of anal human papillomavirus infection among heterosexual men and women in Liuzhou, China: An observational cohort study.
    Int J Cancer. 2019;145:807-816.
    PubMed     Text format     Abstract available

  71. BLANKS R, Buron Pust A, Alison R, He E, et al
    Screen-detected and interval colorectal cancers in England: Associations with lifestyle and other factors in women in a large UK prospective cohort.
    Int J Cancer. 2019;145:728-734.
    PubMed     Text format     Abstract available

  72. KOOYKER AI, Toes-Zoutendijk E, Opstal-van Winden AWJ, Spaander MCW, et al
    The Second Round of The Dutch Colorectal Cancer Screening Program: Impact of An Increased Fit Cut-Off Level on Yield of Screening.
    Int J Cancer. 2019 Dec 19. doi: 10.1002/ijc.32839.
    PubMed     Text format     Abstract available

  73. BENGS S, Becker E, Busenhart P, Spalinger MR, et al
    beta6 -integrin serves as a novel serum tumor marker for colorectal carcinoma.
    Int J Cancer. 2019;145:678-685.
    PubMed     Text format     Abstract available

  74. YANG W, Giovannucci EL, Hankinson SE, Chan AT, et al
    Endogenous sex hormones and colorectal cancer survival among men and women.
    Int J Cancer. 2019 Dec 21. doi: 10.1002/ijc.32844.
    PubMed     Text format     Abstract available

  75. ABRAHAMSSON H, Jensen BV, Berven LL, Nielsen DL, et al
    Antitumour immunity invoked by hepatic arterial infusion of first-line oxaliplatin predicts durable colorectal cancer control after liver metastasis ablation; 8-12 years of follow-up.
    Int J Cancer. 2019 Dec 24. doi: 10.1002/ijc.32847.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  76. LEE SC, Huh JW, Lee WY, Yun SH, et al
    Long-term oncologic outcome and risk factors after conversion in laparoscopic surgery for colon cancer.
    Int J Colorectal Dis. 2019 Dec 23. pii: 10.1007/s00384-019-03489.
    PubMed     Text format     Abstract available

  77. HAJIBANDEH S, Hajibandeh S, Sarma DR, East J, et al
    Meta-analysis of temporary loop ileostomy closure during or after adjuvant chemotherapy following rectal cancer resection: the dilemma remains.
    Int J Colorectal Dis. 2019;34:1151-1159.
    PubMed     Text format     Abstract available

  78. DEIDDA S, Crippa J, Duchalais E, Kelley SR, et al
    Hybrid minimally invasive/open approach versus total minimally invasive approach for rectal cancer resection: short- and long-term results.
    Int J Colorectal Dis. 2019;34:1251-1258.
    PubMed     Text format     Abstract available

  79. YILMAZ A, Mirili C, Bilici M, Tekin SB, et al
    Colorectal cancer in Lynch syndrome associated with PMS2 and MSH6 mutations.
    Int J Colorectal Dis. 2019 Dec 16. pii: 10.1007/s00384-019-03454.
    PubMed     Text format     Abstract available

  80. LARA-ROMERO C, Vilches A, Caunedo-Alvarez A, Hergueta-Delgado P, et al
    Better recurrence-free survival after stent bridge to surgery compared to emergency surgery for obstructive left-sided colonic cancer in patients with stage III status of the American Joint Committee on Cancer (AJCC): a bicentric retrospective study.
    Int J Colorectal Dis. 2019;34:1241-1250.
    PubMed     Text format     Abstract available

  81. WELTEN VM, Fields AC, Lu P, Goldberg JE, et al
    Omental flaps in patients undergoing abdominoperineal resection for rectal cancer.
    Int J Colorectal Dis. 2019;34:1227-1232.
    PubMed     Text format     Abstract available

  82. ZHANG Q, Wang Q, Wang X, Li J, et al
    Regorafenib, TAS-102, or fruquintinib for metastatic colorectal cancer: any difference in randomized trials?
    Int J Colorectal Dis. 2019 Dec 17. pii: 10.1007/s00384-019-03477.
    PubMed     Text format     Abstract available

  83. NIEMELAINEN S, Huhtala H, Ehrlich A, Kossi J, et al
    Risk factors of short-term survival in the aged in elective colon cancer surgery: a population-based study.
    Int J Colorectal Dis. 2019 Dec 18. pii: 10.1007/s00384-019-03488.
    PubMed     Text format     Abstract available

  84. HAN L, Mo S, Xiang W, Li Q, et al
    Prognostic accuracy of different lymph node staging system in predicting overall survival in stage IV colon cancer.
    Int J Colorectal Dis. 2019 Dec 20. pii: 10.1007/s00384-019-03486.
    PubMed     Text format     Abstract available

  85. CROGHAN SM, Zaborowski A, Mohan HM, Mulvin D, et al
    The sentinel stent? A systematic review of the role of prophylactic ureteric stenting prior to colorectal resections.
    Int J Colorectal Dis. 2019;34:1161-1178.
    PubMed     Text format     Abstract available


    Int J Oncol

  86. CHU X, Xue Y, Huo X, Wei J, et al
    Establishment and characterization of a novel cell line (cc006cpm8) of moderately/poorly differentiated colorectal adenocarcinoma derived from a primary tumor of a patient.
    Int J Oncol. 2019;55:243-256.
    PubMed     Text format     Abstract available


    J Clin Oncol

  87. SHUEN AY, Lanni S, Panigrahi GB, Edwards M, et al
    Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue.
    J Clin Oncol. 2019;37:461-470.
    PubMed     Text format     Abstract available

  88. LATHAM A, Srinivasan P, Kemel Y, Shia J, et al
    Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.
    J Clin Oncol. 2019;37:286-295.
    PubMed     Text format     Abstract available

  89. ROVITHI M, Gerritse SL, Honeywell RJ, Ten Tije AJ, et al
    Phase I Dose-Escalation Study of Once Weekly or Once Every Two Weeks Administration of High-Dose Sunitinib in Patients With Refractory Solid Tumors.
    J Clin Oncol. 2019;37:411-418.
    PubMed     Text format     Abstract available

  90. YURGELUN MB, Kastrinos F
    Tumor Testing for Microsatellite Instability to Identify Lynch Syndrome: New Insights Into an Old Diagnostic Strategy.
    J Clin Oncol. 2019;37:263-265.
    PubMed     Text format    


    J Natl Cancer Inst

  91. NOGUEIRA L, Chawla N, Han X, Jemal A, et al
    Colorectal Cancer Care among Young Adult Patients after the Dependent Coverage Expansion under the Affordable Care Act.
    J Natl Cancer Inst. 2019 Dec 19. pii: 5679791. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Pathol

  92. DOSIL MA, Navaridas R, Mirantes C, Tarragona J, et al
    Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis.
    J Pathol. 2019;247:72-85.
    PubMed     Text format     Abstract available

  93. ASHLEY N, Ouaret D, Bodmer WF
    Cellular polarity modulates drug resistance in primary colorectal cancers via orientation of the multidrug resistance protein ABCB1.
    J Pathol. 2019;247:293-304.
    PubMed     Text format     Abstract available

  94. HARUKI K, Kosumi K, Hamada T, Twombly TS, et al
    Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer.
    J Pathol. 2019 Dec 27. doi: 10.1002/path.5381.
    PubMed     Text format     Abstract available


    J Surg Oncol

  95. GOFFREDO P, Zhou P, Ginader T, Hrabe J, et al
    Positive circumferential resection margins following locally advanced colon cancer surgery: Risk factors and survival impact.
    J Surg Oncol. 2019 Dec 18. doi: 10.1002/jso.25801.
    PubMed     Text format     Abstract available

  96. LIMA PMA, Torres LC, Martins MR, da Matta MC, et al
    Soluble levels of sCD40L and s4-1BB are associated with a poor prognosis in elderly patients with colorectal cancer.
    J Surg Oncol. 2019 Dec 19. doi: 10.1002/jso.25813.
    PubMed     Text format     Abstract available

  97. LEIPHRAKPAM PD, Lazenby AJ, Chowdhury S, Smith LM, et al
    Prognostic and therapeutic implications of NHERF1 expression and regulation in colorectal cancer.
    J Surg Oncol. 2019 Dec 22. doi: 10.1002/jso.25805.
    PubMed     Text format     Abstract available


    Lancet

  98. STIRLING P, Moran M
    Now you see it: progressive radiographic findings in avascular necrosis of the hip.
    Lancet. 2019;394:e38.
    PubMed     Text format    


    Nat Rev Cancer

  99. DART A
    Phage warriors.
    Nat Rev Cancer. 2019;19:544-545.
    PubMed     Text format    


    Oncogene

  100. SCHWIEBS A, Herrero San Juan M, Schmidt KG, Wiercinska E, et al
    Cancer-induced inflammation and inflammation-induced cancer in colon: a role for S1P lyase.
    Oncogene. 2019;38:4788-4803.
    PubMed     Text format     Abstract available

  101. SHORT SP, Barrett CW, Stengel KR, Revetta FL, et al
    Kaiso is required for MTG16-dependent effects on colitis-associated carcinoma.
    Oncogene. 2019;38:5091-5106.
    PubMed     Text format     Abstract available

  102. GOWRIKUMAR S, Ahmad R, Uppada SB, Washington MK, et al
    Upregulated claudin-1 expression promotes colitis-associated cancer by promoting beta-catenin phosphorylation and activation in Notch/p-AKT-dependent manner.
    Oncogene. 2019;38:5321-5337.
    PubMed     Text format     Abstract available

  103. RIPANI P, Delp J, Bode K, Delgado ME, et al
    Thiazolides promote G1 cell cycle arrest in colorectal cancer cells by targeting the mitochondrial respiratory chain.
    Oncogene. 2019 Dec 16. pii: 10.1038/s41388-019-1142.
    PubMed     Text format     Abstract available


    Oncol Rep

  104. ANDO N, Hara M, Shiga K, Yanagita T, et al
    Eicosapentaenoic acid suppresses angiogenesis via reducing secretion of IL6 and VEGF from colon cancerassociated fibroblasts.
    Oncol Rep. 2019;42:339-349.
    PubMed     Text format     Abstract available

  105. WANG Y, Zhou L, Qing Q, Li Y, et al
    Gene expression profile of cancer stemlike cells in the SW480 colon adenocarcinoma cell line.
    Oncol Rep. 2019;42:386-398.
    PubMed     Text format     Abstract available


    PLoS One

  106. CHA YJ, Park EJ, Baik SH, Lee KY, et al
    Prognostic impact of persistent lower neutrophil-to-lymphocyte ratio during preoperative chemoradiotherapy in locally advanced rectal cancer patients: A propensity score matching analysis.
    PLoS One. 2019;14:e0214415.
    PubMed     Text format     Abstract available

  107. RENTOFT M, Svensson D, Sjodin A, Olason PI, et al
    A geographically matched control population efficiently limits the number of candidate disease-causing variants in an unbiased whole-genome analysis.
    PLoS One. 2019;14:e0213350.
    PubMed     Text format     Abstract available

  108. AWIDI M, Ababneh N, Shomaf M, Al Fararjeh F, et al
    KRAS and NRAS mutational gene profile of metastatic colorectal cancer patients in Jordan.
    PLoS One. 2019;14:e0226473.
    PubMed     Text format     Abstract available


  109. Epigenetic silencing of peroxisome proliferator-activated receptor gamma is a biomarker for colorectal cancer progression and adverse patients' outcome.
    PLoS One. 2019;14:e0227376.
    PubMed     Text format    

  110. FRANCZAK C, Dubouis L, Gilson P, Husson M, et al
    Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinoma.
    PLoS One. 2019;14:e0212801.
    PubMed     Text format     Abstract available


    World J Surg

  111. LEE CS, Yoon SH, Lee SM, Lee IK, et al
    Micropuncture Access Set Use During Implantation of Totally Implantable Venous Access Device May Reduce Upper Extremity DVT Incidence Among Patients Undergoing Chemotherapy for Colorectal Cancer.
    World J Surg. 2019 Dec 18. pii: 10.1007/s00268-019-05336.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: